Innoviva (INVA) Depreciation & Amortization (CF) (2010 - 2022)
Innoviva posted quarterly Depreciation & Amortization (CF) of $12.5 million for Q3 2022, up 20.54% year-on-year from $10.4 million in Q3 2021, and up 248.29% on a QoQ basis from $3.6 million in Q2 2022.
Innoviva (INVA) has 13 years of Depreciation & Amortization (CF) data on file, last reported at $12.5 million in Q3 2022.
- For the quarter ending Q3 2022, Depreciation & Amortization (CF) rose 20.54% year-over-year to $12.5 million; the trailing twelve-month figure through Jun 2023 stood at $12.5 million (down 28.4% YoY), and the FY2021 full-year result was $13.8 million, changed 0.06% from the prior year.
- Depreciation & Amortization (CF) for Q3 2022 stood at $12.5 million, up from $3.6 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $12.5 million in Q3 2022 and bottomed at $3.3 million in Q3 2019.
- The 5-year median for Depreciation & Amortization (CF) is $3.5 million (2018), against an average of $4.4 million.
- The widest annual swing landed in 2019, when Depreciation & Amortization (CF) decreased 4.27%; it then soared 199.8% in 2021.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $3.5 million in 2018, then climbed by 0.17% to $3.5 million in 2019, then slipped by 0.46% to $3.5 million in 2020, then soared by 200.06% to $10.4 million in 2021, then advanced by 20.54% to $12.5 million in 2022.
- The last three Depreciation & Amortization (CF) figures came in at $12.5 million (Q3 2022), $3.6 million (Q2 2022), and $3.5 million (Q1 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 12.51 Mn |
| Sep 30, 2022 | 12.51 Mn |
| Jun 30, 2022 | 3.59 Mn |
| Jun 30, 2022 | 3.59 Mn |
| Mar 31, 2022 | 3.50 Mn |
| Mar 31, 2022 | 3.50 Mn |
| Sep 30, 2021 | 10.38 Mn |
| Sep 30, 2021 | 10.38 Mn |
| Jun 30, 2021 | 3.46 Mn |
| Jun 30, 2021 | 3.46 Mn |
| Mar 31, 2021 | 3.46 Mn |
| Mar 31, 2021 | 3.46 Mn |
| Dec 31, 2020 | 3.46 Mn |
| Dec 31, 2020 | 3.46 Mn |
| Sep 30, 2020 | 3.46 Mn |
| Sep 30, 2020 | 3.46 Mn |
| Jun 30, 2020 | 3.46 Mn |
| Jun 30, 2020 | 3.46 Mn |
| Mar 31, 2020 | 3.46 Mn |
| Mar 31, 2020 | 3.46 Mn |
| Dec 31, 2019 | 3.47 Mn |
| Dec 31, 2019 | 3.47 Mn |
| Sep 30, 2019 | 3.32 Mn |
| Sep 30, 2019 | 3.32 Mn |
| Jun 30, 2019 | 3.54 Mn |
| Jun 30, 2019 | 3.54 Mn |
| Mar 31, 2019 | 3.54 Mn |
| Mar 31, 2019 | 3.54 Mn |
| Dec 31, 2018 | 3.47 Mn |
| Dec 31, 2018 | 3.47 Mn |
| Sep 30, 2018 | 3.47 Mn |
| Sep 30, 2018 | 3.47 Mn |
| Jun 30, 2018 | 3.47 Mn |
| Jun 30, 2018 | 3.47 Mn |
| Mar 31, 2018 | 3.47 Mn |
| Mar 31, 2018 | 3.47 Mn |
| Dec 31, 2017 | 3.50 Mn |
| Dec 31, 2017 | 3.50 Mn |
| Sep 30, 2017 | 3.50 Mn |
| Sep 30, 2017 | 3.50 Mn |
| Jun 30, 2017 | 3.50 Mn |
| Jun 30, 2017 | 3.50 Mn |
| Mar 31, 2017 | 3.50 Mn |
| Mar 31, 2017 | 3.50 Mn |
| Dec 31, 2016 | 3.50 Mn |
| Dec 31, 2016 | 3.50 Mn |
| Sep 30, 2016 | 3.49 Mn |
| Sep 30, 2016 | 3.49 Mn |
| Jun 30, 2016 | 3.48 Mn |
| Jun 30, 2016 | 3.48 Mn |
| Mar 31, 2016 | 3.48 Mn |
| Mar 31, 2016 | 3.48 Mn |
| Dec 31, 2015 | 3.48 Mn |
| Dec 31, 2015 | 3.48 Mn |
| Sep 30, 2015 | 3.48 Mn |
| Sep 30, 2015 | 3.48 Mn |
| Jun 30, 2015 | 3.48 Mn |
| Jun 30, 2015 | 3.48 Mn |
| Mar 31, 2015 | 3.48 Mn |
| Mar 31, 2015 | 3.48 Mn |
| Dec 31, 2014 | 3.46 Mn |
| Dec 31, 2014 | 3.46 Mn |
| Sep 30, 2014 | 2.53 Mn |
| Sep 30, 2014 | 2.53 Mn |
| Jun 30, 2014 | 3.55 Mn |
| Jun 30, 2014 | 3.55 Mn |
| Mar 31, 2014 | 2.64 Mn |
| Mar 31, 2014 | 2.64 Mn |
| Dec 31, 2013 | 1.50 Mn |
| Dec 31, 2013 | 1.50 Mn |
| Sep 30, 2013 | -77,000.00 |
| Sep 30, 2013 | -77,000.00 |
| Jun 30, 2013 | 138,000.00 |
| Jun 30, 2013 | 138,000.00 |
| Mar 31, 2013 | 1.90 Mn |
| Mar 31, 2013 | 1.90 Mn |
| Dec 31, 2012 | -2.21 Mn |
| Dec 31, 2012 | -2.21 Mn |
| Sep 30, 2012 | 1.89 Mn |
| Sep 30, 2012 | 1.89 Mn |
| Jun 30, 2012 | 1.66 Mn |
| Jun 30, 2012 | 1.66 Mn |
| Mar 31, 2012 | 1.91 Mn |
| Mar 31, 2012 | 1.91 Mn |
| Dec 31, 2011 | 2.12 Mn |
| Dec 31, 2011 | 2.12 Mn |
| Sep 30, 2011 | 2.05 Mn |
| Sep 30, 2011 | 2.05 Mn |
| Jun 30, 2011 | 1.76 Mn |
| Jun 30, 2011 | 1.76 Mn |
| Mar 31, 2011 | 1.65 Mn |
| Mar 31, 2011 | 1.65 Mn |
| Dec 31, 2010 | 1.64 Mn |
| Dec 31, 2010 | 1.64 Mn |
| Sep 30, 2010 | 1.56 Mn |
| Sep 30, 2010 | 1.56 Mn |